Endoscopic Healing of Crohn's Disease Could Differ by Biologic

Infliximab biosimilar and adalimumab resulted in better endoscopic healing rates than either vedolizumab or ustekinumab in a post hoc pooled analysis.
Medscape Medical News

source https://www.medscape.com/viewarticle/969563?src=rss